Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01054469 · ClinicalTrials.gov registry record · NA
Transversus Abdominus Plane Block
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT01054469: Completed NA study, sponsored by Mayo Clinic.
NCT01054469 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 21 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01054469, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
Transversus Abdominus Plane (TAP) block may reduce need for postoperative pain medications in patients undergoing laparoscopic hand assisted nephrectomy. Our hypothesis is that the TAP block will result in a significant reduction in pain scores and morphine requirements in the active group.
Interventions
- PROCEDURE TAP block placement with placebo
- PROCEDURE Placement of block with ropivacaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2010-03 |
| Est. Completion | 2012-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01054469
The ClinicalTrials.gov registry entry for NCT01054469 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which TAP block placement with placebo is the first listed.
NCT01054469 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01054469 about?
NCT01054469 is a clinical study titled "Transversus Abdominus Plane Block". Transversus Abdominus Plane (TAP) block may reduce need for postoperative pain medications in patients undergoing laparoscopic hand assisted nephrectomy. Our hypothesis is that the TAP block will result in a significant reduction in pain scores and morphine requirements in the active group.
What is the current status of trial NCT01054469?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2010-03. Estimated completion is 2012-02.
What interventions are being tested in trial NCT01054469?
The interventions under investigation include: TAP block placement with placebo (PROCEDURE), Placement of block with ropivacaine (PROCEDURE).
Who is sponsoring clinical trial NCT01054469?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.